JOINT FILING AGREEMENT
Exhibit 3
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each
of the persons named below agrees to the joint filing of a Statement on Schedule 13D (including
amendments thereto) with respect to the common stock, $0.0001 par value per share, of Targanta
Therapeutics Corporation, a Delaware corporation, and further agrees that this Joint Filing
Agreement be included as an exhibit to such filings provided that, as contemplated by
Section 13d-1(k)(ii), no person shall be responsible for the completeness or accuracy of the
information concerning the other persons making the filing, unless such person knows or has reason
to believe that such information is inaccurate.
Dated: January 22, 2009
THE MEDICINES COMPANY |
||||
/s/ Xxxx X. Xxxxxxxx | ||||
Xxxx X. Xxxxxxxx | ||||
General Counsel & Senior Vice President |
Dated: January 22, 2009
BOXFORD SUBSIDIARY CORPORATION |
||||
/s/ Xxxx X. Xxxxxxxx | ||||
Xxxx X. Xxxxxxxx | ||||
Secretary | ||||